Colle Capital Partners — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Sensydia develops the Cardiac Performance System (CPS), a non-invasive, automated platform that uses disposable sensors to measure advanced hemodynamic metrics such as ejection fraction, cardiac output, and pulmonary artery pressure.
HardwareHealthtechMedical DevicesLos Angeles, US
BoardG. Bradford Jones(Director)William Kaiser(Executive Officer)inVictoria K. Grace(Director)inAman Mahajan(Executive Officer, Director)Thomas Bruggere(Executive Officer, Director)
Board seatVictoria Grace· per SEC Form D
Co-investorsFrontier Venture CapitalOrlando Health Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.